Question:
Pantimumab
Author: SuzukiAnswer:
Panitumumab is a fully human monoclonal antibody directed against the EGFR; it is approved for refractory metastatic colorectal cancer.
0 / 5 Â (0 ratings)
1 answer(s) in total
Author
Suzuki
Answer:
0 / 5 Â (0 ratings)
1 answer(s) in total